{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:23:57Z","timestamp":1778088237923,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/aps.2017.127","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T10:01:39Z","timestamp":1505988099000},"page":"1601-1610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis"],"prefix":"10.1038","volume":"38","author":[{"given":"Yong-qiang","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-zhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-lu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"BFaps2017127_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","volume":"23","author":"M Pagadala","year":"2012","unstructured":"Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP . Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab 2012; 23: 365\u201371.","journal-title":"Trends Endocrinol Metab"},{"key":"BFaps2017127_CR2","first-page":"S17","volume":"40","author":"AJ McCullough","year":"2006","unstructured":"McCullough AJ . Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40: S17\u201329.","journal-title":"J Clin Gastroenterol"},{"key":"BFaps2017127_CR3","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1074\/jbc.M112.431627","volume":"288","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem 2013; 288: 9583\u201392.","journal-title":"J Biol Chem"},{"key":"BFaps2017127_CR4","doi-asserted-by":"publisher","first-page":"12336","DOI":"10.1074\/jbc.M115.702654","volume":"291","author":"Y Pang","year":"2016","unstructured":"Pang Y, Li Y, Lv Y, Sun L, Zhang S, Li Y, et al. Intermedin restores hyperhomocysteinemia-induced macrophage polarization and improves insulin resistance in mice. J Biol Chem 2016; 291: 12336\u201345.","journal-title":"J Biol Chem"},{"key":"BFaps2017127_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.yjmcc.2015.02.005","volume":"81","author":"W Sun","year":"2015","unstructured":"Sun W, Pang Y, Liu Z, Sun L, Liu B, Xu M, et al. Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm. J Mol Cell Cardiol 2015; 81: 96\u2013106.","journal-title":"J Mol Cell Cardiol"},{"key":"BFaps2017127_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2337\/db07-0617","volume":"57","author":"Y Li","year":"2008","unstructured":"Li Y, Jiang C, Xu G, Wang N, Zhu Y, Tang C, et al. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes 2008; 57: 817\u201327.","journal-title":"Diabetes"},{"key":"BFaps2017127_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.RES.0000087642.01082.E4","volume":"93","author":"X Zeng","year":"2003","unstructured":"Zeng X, Dai J, Remick DG, Wang X . Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 2003; 93: 311\u201320.","journal-title":"Circ Res"},{"key":"BFaps2017127_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1440-1746.2005.03891.x","volume":"20","author":"M Gulsen","year":"2005","unstructured":"Gulsen M, Yesilova Z, Bagci S, Uygun A, Ozcan A, Ercin CN, et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2005; 20: 1448\u201355.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFaps2017127_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/hep.28518","volume":"64","author":"L Yao","year":"2016","unstructured":"Yao L, Wang C, Zhang X, Peng L, Liu W, Zhang X, et al. Hyperhomocysteinemia activates the aryl hydrocarbon receptor\/CD36 pathway to promote hepatic steatosis in mice. Hepatology 2016; 64: 92\u2013105.","journal-title":"Hepatology"},{"key":"BFaps2017127_CR10","doi-asserted-by":"publisher","first-page":"E1002","DOI":"10.1152\/ajpendo.00518.2004","volume":"288","author":"CW Woo","year":"2005","unstructured":"Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, et al. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 2005; 288: E1002\u201310.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFaps2017127_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jep.2011.01.021","volume":"134","author":"N Morihara","year":"2011","unstructured":"Morihara N, Ide N, Weiss N . Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human macrophages in vitro. J Ethnopharmacol 2011; 134: 711\u20136.","journal-title":"J Ethnopharmacol"},{"key":"BFaps2017127_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-nutr-071714-034410","volume":"35","author":"T Ulven","year":"2015","unstructured":"Ulven T, Christiansen E . Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4\/GPR120. Annu Rev Nutr 2015; 35: 239\u201363.","journal-title":"Annu Rev Nutr"},{"key":"BFaps2017127_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/aps.2016.135","volume":"38","author":"Q Huang","year":"2017","unstructured":"Huang Q, Wang T, Wang HY . Ginsenoside Rb2 enhances the anti-inflammatory effect of omega-3 fatty acid in LPS-stimulated RAW264.7 macrophages by upregulating GPR120 expression. Acta Pharmacol Sin 2017; 38: 192\u2013200.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2017127_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1053\/jhep.2003.09028","volume":"38","author":"M Sekiya","year":"2003","unstructured":"Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529\u201339.","journal-title":"Hepatology"},{"key":"BFaps2017127_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jnutbio.2014.04.011","volume":"25","author":"CG Dossi","year":"2014","unstructured":"Dossi CG, Tapia GS, Espinosa A, Videla LA, D'Espessailles A . Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-alpha and SREBP-1c. J Nutr Biochem 2014; 25: 977\u201384.","journal-title":"J Nutr Biochem"},{"key":"BFaps2017127_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jhep.2013.11.006","volume":"60","author":"DA Raptis","year":"2014","unstructured":"Raptis DA, Limani P, Jang JH, Ungethum U, Tschuor C, Graf R, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of omega3-fatty acids. J Hepatol 2014; 60: 625\u201332.","journal-title":"J Hepatol"},{"key":"BFaps2017127_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12986-015-0054-x","volume":"12","author":"P Xu","year":"2015","unstructured":"Xu P, Wang H, Kayoumu A, Wang M, Huang W, Liu G . Diet rich in Docosahexaenoic Acid\/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice. Nutr Metab (Lond) 2015; 12: 58.","journal-title":"Nutr Metab (Lond)"},{"key":"BFaps2017127_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1021\/pr501200u","volume":"14","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yang N, Ai D, Zhu Y . Systematic metabolomic analysis of eicosanoids after Omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography-tandem mass spectrometry-based method. J Proteome Res 2015; 14: 1843\u201353.","journal-title":"J Proteome Res"},{"key":"BFaps2017127_CR19","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1038\/ncomms10166","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Lv Y, Li J, Krausz KW, Shi J, et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun 2015; 6: 10166.","journal-title":"Nat Commun"},{"key":"BFaps2017127_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/aps.2016.175","volume":"38","author":"B Zhou","year":"2017","unstructured":"Zhou B, Zhou DL, Wei XH, Zhong RY, Xu J, Sun L . Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation. Acta Pharmacol Sin 2017; 38: 998\u20131008.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2017127_CR21","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.3390\/nu8090543","volume":"8","author":"NK Soni","year":"2016","unstructured":"Soni NK, Ross AB, Scheers N, Savolainen OI, Nookaew I, Gabrielsson BG, et al. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays skeletal muscle degradation in mice. Nutrients 2016; 8. pii: E543.","journal-title":"Nutrients"},{"key":"BFaps2017127_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P . Nonalcoholic fatty liver disease. New Engl J Med 2002; 346: 1221\u201331.","journal-title":"New Engl J Med"},{"key":"BFaps2017127_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508\u201314.","journal-title":"J Hepatol"},{"key":"BFaps2017127_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/aps.2016.158","volume":"38","author":"MX Liu","year":"2017","unstructured":"Liu MX, Gao M, Li CZ, Yu CZ, Yan H, Peng C, et al. Dicer1\/miR-29\/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. Acta Pharmacol Sin 2017; 38: 660\u201371.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2017127_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1053\/j.gastro.2005.02.034","volume":"128","author":"K Robert","year":"2005","unstructured":"Robert K, Nehme J, Bourdon E, Pivert G, Friguet B, Delcayre C, et al. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005; 128: 1405\u201315.","journal-title":"Gastroenterology"},{"key":"BFaps2017127_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, Zhou Y, Sadevirta S, Leivonen M, Arola J, Oresic M, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 2016; 64: 1167\u201375.","journal-title":"J Hepatol"},{"key":"BFaps2017127_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","volume":"5","author":"WL Holland","year":"2007","unstructured":"Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167\u201379.","journal-title":"Cell Metab"},{"key":"BFaps2017127_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur S, Wang ST, Chan PW, Li Y, Ching J, Chaurasia B, et al. CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 2014; 20: 687\u201395.","journal-title":"Cell Metab"},{"key":"BFaps2017127_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 2014; 20: 678\u201386.","journal-title":"Cell Metab"},{"key":"BFaps2017127_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 2015; 125: 386\u2013402.","journal-title":"J Clin Invest"},{"key":"BFaps2017127_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/alcalc\/agv119","volume":"51","author":"L Yang","year":"2016","unstructured":"Yang L, Jin GH, Zhou JY . The role of ceramide in the pathogenesis of alcoholic liver disease. Alcohol Alcohol 2016; 51: 251\u20137.","journal-title":"Alcohol Alcohol"},{"key":"BFaps2017127_CR32","doi-asserted-by":"publisher","first-page":"G1004","DOI":"10.1152\/ajpgi.00482.2009","volume":"298","author":"S Liangpunsakul","year":"2010","unstructured":"Liangpunsakul S, Sozio MS, Shin E, Zhao ZW, Xu Y, Ross RA, et al. Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels. Am J Physiol Gastrointest Liver Physiol 2010; 298: G1004\u201312.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFaps2017127_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00125-015-3850-y","volume":"59","author":"BC Bergman","year":"2016","unstructured":"Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, et al. Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans. Diabetologia 2016; 59: 785\u201398.","journal-title":"Diabetologia"},{"key":"BFaps2017127_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hep.26606","volume":"59","author":"R Cinar","year":"2014","unstructured":"Cinar R, Godlewski G, Liu J, Tam J, Jourdan T, Mukhopadhyay B, et al. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Hepatology 2014; 59: 143\u201353.","journal-title":"Hepatology"},{"key":"BFaps2017127_CR35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.12331","volume":"34","author":"K Kurek","year":"2014","unstructured":"Kurek K, Piotrowska DM, Wiesiolek-Kurek P, Lukaszuk B, Chabowski A, Gorski J, et al. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver Int 2014; 34: 1074\u201383.","journal-title":"Liver Int"},{"key":"BFaps2017127_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4161\/isl.20102","volume":"4","author":"E Boslem","year":"2012","unstructured":"Boslem E, Meikle PJ, Biden TJ . Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction. Islets 2012; 4: 177\u201387.","journal-title":"Islets"},{"key":"BFaps2017127_CR37","doi-asserted-by":"publisher","first-page":"16901","DOI":"10.1074\/jbc.274.24.16901","volume":"274","author":"JY Lehtonen","year":"1999","unstructured":"Lehtonen JY, Horiuchi M, Daviet L, Akishita M, Dzau VJ . Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 1999; 274: 16901\u20136.","journal-title":"J Biol Chem"},{"key":"BFaps2017127_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0014-5793(01)02625-4","volume":"503","author":"GS Dbaibo","year":"2001","unstructured":"Dbaibo GS, El-Assaad W, Krikorian A, Liu B, Diab K, Idriss NZ, et al. Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett 2001; 503: 7\u201312.","journal-title":"FEBS Lett"},{"key":"BFaps2017127_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.ki.5001517","volume":"70","author":"F Yi","year":"2006","unstructured":"Yi F, Zhang AY, Li N, Muh RW, Fillet M, Renert AF, et al. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int 2006; 70: 88\u201396.","journal-title":"Kidney Int"},{"key":"BFaps2017127_CR40","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/j.1523-1755.2004.00968.x","volume":"66","author":"F Yi","year":"2004","unstructured":"Yi F, Zhang AY, Janscha JL, Li PL, Zou AP . Homocysteine activates NADH\/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 2004; 66: 1977\u201387.","journal-title":"Kidney Int"},{"key":"BFaps2017127_CR41","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.ajpath.2011.07.019","volume":"179","author":"KM Boini","year":"2011","unstructured":"Boini KM, Xia M, Li C, Zhang C, Payne LP, Abais JM, et al. Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice. Am J Pathol 2011; 179: 2210\u20139.","journal-title":"Am J Pathol"},{"key":"BFaps2017127_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","volume":"33","author":"E Scorletti","year":"2013","unstructured":"Scorletti E, Byrne CD . Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr 2013; 33: 231\u201348.","journal-title":"Annu Rev Nutr"},{"key":"BFaps2017127_CR43","first-page":"pii","volume":"8","author":"JY Zheng","year":"2016","unstructured":"Zheng JY, Peng C, Ai YB, Wang H, Xiao XQ, Li JB . Docosahexaenoic acid ameliorates fructose-induced hepatic steatosis involving ER stress response in primary mouse hepatocytes. Nutrients 2016; 8. pii: E55.","journal-title":"Nutrients"},{"key":"BFaps2017127_CR44","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1167\/iovs.09-4731","volume":"51","author":"M Opreanu","year":"2010","unstructured":"Opreanu M, Lydic TA, Reid GE, McSorley KM, Esselman WJ, Busik JV . Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2010; 51: 3253\u201363.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2017127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017127","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:35:25Z","timestamp":1684413325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2017127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFaps2017127"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.127","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"12 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}